Medco Health Solutions Inc.'s fourth-quarter net income rose 12 percent, as gains from generic prescriptions and the pharmacy benefits manager's specialty business helped offset costs from its pending acquisition by Express Scripts Inc.
A generic version of the cholesterol fighter Lipitor added about 3 cents per share to the Franklin Lakes, N.J., company's earnings. Lipitor, the world's top selling drug, lost its patent protection late in the fourth quarter.
Medco said Tuesday its generic dispensing rate climbed 2.5 percentage points in the quarter to 74.7 percent of total prescription volume. Generic drugs are less expensive than their brand-name counterparts, so they can hurt revenue for pharmacy benefits managers, or PBMs, but improve profit margins.
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
